• /ylen/upload/images/2020/5/fe92d3da0b24bbce.jpg
    China Focus: Chinese medicine against COVID-19 gets market entry to Singapore

    Clinical observation in designated COVID-19 hospitals in China has showed that TCM including the Lianhua Qingwen Capsule are effective in the treatment of over 90 percent of all confirmed COVID-19 cases on the Chinese mainland.

  • /ylen/upload/images/2020/5/f676dadd998a75f0.jpg
    Lianhua Qingwen Receives Product Listing Approval from Singapore HSA

    Developed under the guidance of collateral disease theory, the medicine is listed as the recommended medicine for the treatment of cold and influenza by China’s National Health Commission and National Administration of Traditional Chinese Medicine. Composed of 13 Chinese herbs, the TCM has been found in the clinical research that it is effective in alleviating the influenza-induced symptoms like fever, cough and fugue.

  • /ylen/upload/images/2020/5/746f5bc1f9e441e1.jpeg
    No evidence mosquitoes can pass coronavirus: top expert

    There is no evidence so far that the coronavirus can be transmitted by mosquitoes, China's top respiratory expert, Zhong Nanshan, said on Monday during a video conference with staff members from the Confucius Institute and Chinese students studying abroad.

  • /ylen/upload/images/2020/4/c4bc28df43cfb1fe.jpg
    Obat Pneumonia Koroner Dibutuhkan untuk Bantu Pasien Corona

    JAKARTA - Penyebaran wabah virus Corona (Covid-19) di dunia masih belum mereda termasuk di Indonesia. Pemasalahannya sampai saat ini belum ada vaksin dan obat khusus untuk menyembuhkan pasien Covid-19.

  • /ylen/upload/images/2020/4/17ddb0c62a2336ae.jpg
    Lianhua Qingwen listada no esquema de diagnóstico e tratamento da pneumonia pelo novo coronavírus no Laos

    SHIJIAZHUANG, China, 23 de abril de 2020 /PRNewswire/ -- A Yiling Pharmaceutical (002603.SZ) anunciou que as cápsulas (grânulos) da Lianhua Qingwen foram adicionadas ao "Esquema de diagnóstico e tratamento da pneumonia pelo novo coronavírus no Laos" (Versão II do Estudo) como o quarto medicamento tradicional chinês para o tratamento da pneumonia por COVID-19 no Laos.